Japanese Trade Group Calls For Relaxation of Regulation To Boost Foreign Medical Device Import
This article was originally published in PharmAsia News
Aiming to erase the medical device lag in Japan, the Expert Committee on Foreign Direct Investment to Japan, a trade and economic promotional organization, released a proposal to increase efficiency in the medical device review and approval process. The committee calls for an increased budget to strengthen the workforce and reduce unnecessary ministerial level reviews for some foreign devices. The committee also calls to revise operational rules of the Ministry of Health, Labor and Welfare's Food and Drug Safety Council, which controls the final phase in a review process. The summary will be submitted to the Council on Economy and Fiscal. (Click here for more - Japanese language) "Expert Committee Calls For Relaxation In Regulation To Boost Foreign Medical Device Entry" - Sankei News (4/18/08)
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.